BML, Inc. (MUN:BMZ)

Germany flag Germany · Delayed Price · Currency is EUR
20.00
-0.20 (-0.99%)
Last updated: Oct 29, 2025, 8:01 AM CET
-0.99%
Market Cap747.40M
Revenue (ttm)859.46M
Net Income (ttm)37.88M
Shares Outn/a
EPS (ttm)0.97
PE Ratio19.73
Forward PEn/a
Dividend0.77 (3.87%)
Ex-Dividend DateSep 29, 2025
Volumen/a
Average Volumen/a
Open20.00
Previous Close20.20
Day's Range20.00 - 20.00
52-Week Range16.20 - 21.20
Betan/a
RSI39.34
Earnings DateNov 7, 2025

About BML, Inc.

BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispe... [Read more]

Industry Commercial Physical and Biological Research
Founded 1955
Employees 4,558
Stock Exchange Munich Stock Exchange
Ticker Symbol BMZ
Full Company Profile

Financial Performance

In 2024, BML, Inc.'s revenue was 143.19 billion, an increase of 3.79% compared to the previous year's 137.96 billion. Earnings were 6.26 billion, an increase of 3.80%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.